截至2025年12月22日收盘，万孚生物(300482)报收于19.88元，下跌0.95%，换手率0.85%，成交量3.65万 手，成交额7280.52万元。 董秘最新回复 投资者： 1. 尊敬的董秘，您好！当前全国多地密集出台生育补贴、辅助生殖医保全覆盖、育儿假延长 等生育支持政策，国家层面也明确推进育儿补贴制度和生育保障优化，请问公司是否已全面跟踪全国性 生育政策落地动态？针对政策红利集中的省份，优生优育板块（如"金秀儿"系列、精子质量检测产品 等）是否有全国性的渠道拓展或区域差异化推广策略？谢谢！ 董秘： 尊敬的投资者您好，公司产品覆盖九大技术平台，时刻关注不同应用场景下的业务机会，感谢 您的关注。 投资者： 面对各地辅助生殖补贴加码、生育支持政策密集出台的情况，公司是否有计划扩大优生优育 检测板块产能或研发新品（如辅助生殖术前筛查试剂），以提升营收占比？ 董秘： 尊敬的投资者您好！感谢您对公司的关注。万孚生物始终密切跟踪医疗健康领域相关政策动 态，围绕临床诊疗需求与民生健康需求开展产品研发及场景适配工作。在优生优育领域，公司具有丰富 产品线，包括产前的传染病监测、生殖能力检测等产品，可以覆盖绝大多数优 ...

格隆汇12月22日丨万孚生物(300482.SZ)在互动平台表示，万孚生物始终密切跟踪医疗健康领域相关政 策动态，围绕临床诊疗需求与民生健康需求开展产品研发及场景适配工作。在优生优育领域，公司具有 丰富产品线，包括产前的传染病监测、生殖能力检测等产品，可以覆盖绝大多数优生优育需求。公司亦 会根据市场需求动态调整推广及供应策略。 ...

格隆汇12月22日丨万孚生物(300482.SZ)在互动平台表示，万孚生物始终密切跟踪医疗健康领域相关政 策动态，围绕临床诊疗需求与民生健康需求开展产品研发及场景适配工作。在优生优育领域，公司具有 丰富产品线，包括产前的传染病监测、生殖能力检测等产品，可以覆盖绝大多数优生优育需求。公司亦 会根据市场需求动态调整推广及供应策略。 ...

Core Insights - The Shenzhen Maternal and Child Health Hospital (Longgang Maternal and Child Health) showcased its specialized obstetric and postpartum care services at the 2025 Shenzhen Expo, emphasizing maternal and infant health and regional medical collaboration [1] - The hospital's director highlighted the need for a resilient maternal and child service system that requires collaboration among government, hospitals, communities, and families [1] - The hospital has implemented innovative models in the construction of a preterm birth sub-specialty, achieving significant improvements in the quality of care for preterm infants through multidisciplinary collaboration and standardized treatment processes [2] Group 1 - The Longgang Maternal and Child Health Hospital has established an integrated management model for preterm birth prevention and treatment, providing comprehensive services including pre-pregnancy consultation and risk assessment [2] - The hospital has successfully performed over 400 cervical cerclage surgeries and pioneered cervical support therapy in Guangdong Province, significantly extending gestational weeks for many patients [2] - The hospital has launched an "Internet + Continuity of Care" service, covering the entire maternal and infant health lifecycle and providing 24-hour consultation and home services [2] Group 2 - The series of initiatives by Longgang Maternal and Child Health Hospital demonstrates its practical achievements in promoting optimal birth and comprehensive maternal and child health services [3] - The hospital's efforts provide a model for constructing a responsive and comprehensive maternal and child service system [3]

Group 1 - The company, Kehua Bio (002022), stated on July 31 that it does not have products or business in the field of assisted reproduction [1] - The company and its subsidiaries have diagnostic products related to prenatal health, such as the Anti-Müllerian Hormone (AMH) assay kit (chemiluminescence method) and the Survival Motor Neuron 1 (SMN1) detection kit (PCR melting curve method) [1]

Group 1 - The core viewpoint of the article is that Kehua Bio (002022) has partnered with Waters to provide a dual-brand high-performance liquid chromatography-tandem mass spectrometry solution, which includes a series of equipment and testing reagents [1] - The solution aims to cover areas from pre-pregnancy precise cause screening, nutritional monitoring during pregnancy, to newborn disease prevention, thereby supporting better reproductive health [1] - The company advises investors to be cautious of concept speculation and to make rational investment decisions while being aware of investment risks [1]

Core Viewpoint - Kehua Bio (002022.SZ) does not have products or business in the assisted reproduction field, but it offers diagnostic products related to prenatal care [1] Group 1 - The company has diagnostic products in the field of prenatal care, including the Anti-Müllerian Hormone (AMH) assay kit (chemiluminescence method) [1] - The company also provides the Survival Motor Neuron 1 (SMN1) detection kit (PCR-melting curve method) [1]

Group 1 - The company does not have products or business related to assisted reproductive technology [2] - The company and its subsidiaries have diagnostic products in the field of reproductive health, such as the Anti-Müllerian Hormone (AMH) assay kit and the Survival Motor Neuron 1 (SMN1) detection kit [2]

Core Viewpoint - The 2025 Shenzhen Excellent Childbirth and Parenting Expo, known as "Shenzhen Youbohui," will take place on August 23-24 at the Shenzhen Convention Center, showcasing innovative health technology products for maternal and infant families, particularly highlighting the brand "Xiao Zhi Fu Dong" under Shenzhen Gallium Electric Technology Co., Ltd. [1] Company Overview - Shenzhen Gallium Electric Technology Co., Ltd. was established in September 2022 by leading national technology innovators and key personnel from Huawei and ZTE, headquartered in Qianhai, Shenzhen [3] - The company aims to create a "zero-contact health protection line," focusing on the development of smart living paper and health technology products, positioning itself as a high-end health technology brand targeting health-conscious families, women, and maternal-infant groups [3] - "Xiao Zhi Fu Dong" is the world's first smart living paper brand, emphasizing a unique market position with a cross-industry chain of "multi-functional paper + smart devices + remote management" [3] Product Highlights - At the expo, "Xiao Zhi Fu Dong" will present two core products: 1. The XZ-001 wall-mounted tissue machine, which is multifunctional, features UV/ozone sterilization, maintains a constant temperature of 39°C, offers contactless paper dispensing, and is the world's first to produce ozone wet wipes [3] 2. The multi-functional living paper, made from 100% natural raw materials without chemical additives, is eight times thicker and six times more absorbent than regular tissues, dissolving in five seconds when flushed [3] Marketing Strategy - The company chose the Youbohui as a promotional platform due to its unique advantages, integrating a full-cycle ecosystem from "pre-pregnancy to parenting" with various activities, which helps raise awareness of the health benefits of "Xiao Zhi Fu Dong" products [7] - The expo's cross-border collaboration between Shenzhen and Hong Kong provides opportunities to reach more consumers in Hong Kong, aligning with their high standards for sterility and quality [7] - "Xiao Zhi Fu Dong" has established partnerships with well-known hotels, housekeeping services, fitness clubs, and training institutions, and aims to connect with medical institutions, childcare centers, and maternity service providers through the expo [7][8] Future Plans - In response to the upgraded "excellent childbirth and parenting" concept, the company has a clear strategic plan to deepen technological research and develop more smart home health products, such as sterilization devices for infants, expanding the "zero-contact health protection" scenarios [8] - The company aims to provide personalized health paper data analysis services, driven by technology and environmental sustainability, aspiring to become a "safety standard setter" in the maternal and infant health sector [8]

Core Viewpoint - The articles emphasize the importance of scientific guidance in reproductive health and the need for fertility assessments to improve birth outcomes and address infertility issues among couples. Group 1: Importance of Fertility Assessment - Fertility assessments can help identify potential genetic issues and allow for early intervention, reducing risks associated with pregnancy and improving maternal and fetal health [2][3] - The establishment of fertility assessment clinics is encouraged to raise awareness about changes in reproductive capabilities as individuals age [1][2] Group 2: Public Education on Reproductive Health - There is a lack of public education on how to plan for healthy pregnancies, with current education primarily focused on contraception rather than fertility [2] - Nutritional guidance before pregnancy is often insufficient, despite the importance of balanced nutrition for successful conception [2] Group 3: Factors Affecting Reproductive Health - Weight management is crucial for reproductive health, with recommendations for individuals with conditions like polycystic ovary syndrome to manage their weight effectively [3] - Psychological factors, lifestyle choices, and health conditions can significantly impact fertility, highlighting the need for regular health check-ups for couples planning to conceive [3]